Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

By S. Gill, C. Loprinzi, D. Sargent, S. Thomé, S. Alberts, D. Haller, J. Benedetti, G. Francini, L. Shepherd, Jean Francois Seitz and 5 more. Journal of Clinical Oncology, 2004

1,033 citations recorded by the source corpus.

Subfields: Oncology

View Paper: https://www.semanticscholar.org/paper/4e95b1e5fa87fabdd86beeff0eef5da197b14727

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. John P. A. Ioannidis
2. Paul E. Smaldino
3. Daniël Lakens
4. Brian A. Nosek
5. Bryan G. Cook
6. Jana Winter
7. Valen E. Johnson
8. John Antonakis

Citations in the corpus

• Contradicted and initially stronger effects in highly cited clinical research. (2005, result): “The findings of 20 highly cited articles (44%) were replicated (also with a larger sample size in subsequent research compared with the original highly cited study) and 11 (24%) had remained largely unchallenged.(58-78)”